Table 2 The expression of SFRP1 versus clinical features

Gender

male

40

32 (80.2%)

8 (20.0%)

2.770

0.065

female

6

3 (50.0%)

3 (50.0%)

Age

≥60

7

5 (71.4%)

2 (28.6%)

0.098

0.754

<60

39

30 (76.9%)

9 (23.1%)

Tumor Size (cm)

>3 cm

39

31 (45.5%)

8 (54.5%)

1.629

0.202

≤3 cm

7

4 (37.5%)

3 (62.5%)

D8S532

LOH+

6

5 (83.3%)

1 (16.7%)

0.361

0.548

LOH-

40

30 (75%)

10 (25%)

D8SAC016868

LOH+

3

3 (100.0%)

0

1.30

0.254

LOH-

43

32 (74.4%)

11 (25.6%)